The goal of this MidAtlantic AIDS Education and Training Center (MAAETC) project is to create a Prevention Community of Practice (P-CoP) focused on increasing HIV testing and use of pre-exposure prophylaxis (PrEP) knowledge and readiness to prescribe in Federally Qualified Health Centers (FQHCs). As a result, increased numbers of health professionals at FQHCs will be able to competently deploy evidence-based prevention strategies, including PrEP, that focus on people who are at risk for HIV. Health Resources and Services Administration (HRSA) Bureau of Primary Health Care (BPHC) supports this initiative to partner with Ending the HIV Epidemic-funded FQHCs in the MAAETC region to increase the numbers of health professionals prepared to provide PrEP, including improving access to care and patient outcomes.

Program Code: 22256 

Target Audience: Physicians, Nurses, Nurse Practitioners, and others medical team members involved in supporting patients prescribed PrEP

Learning Objectives: After this activity, participants should be able to: 1. Demonstrate competence in sexual health history taking, and PrEP assessment and prescribing. 2. Conduct effective interviews with patients to counsel them on PrEP and develop plans for treatment. 3. Perform appropriate clinical examinations and demonstrate competence in STI assessment, HIV testing, and PrEP management.

CME ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Drexel University College of Medicine and the MidAtlantic AIDS Education and Training Center of the Health Federation of Philadelphia.  The Drexel College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement: The Drexel University College of Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA: This program is eligible for 3.0 credits in Category 2A of the American Osteopathic Association

Nursing: The MidAtlantic AIDS Education and Training Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association Approver Unit an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This event is eligible for 1.0 credit hours.

Certificate of Attendance: Continuing Education credits issued for participation in CE activity may not apply toward license renewal in all states.  It is the responsibility of each participant to verify the requirements of their state licensing board(s).

FACULTY DISCLOSURE STATEMENT: It is the policy of Drexel University College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. Speakers at continuing medical education activities are required to disclose to the audience, any relevant commercial interest (which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience. The intent of this disclosure is to allow participants to form their own judgments about the educational content of this activity and determine whether the speaker’s commercial interests influenced the presentation. In addition, speakers are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation.

FACULTY DISCLOSURE STATEMENT: Speakers at continuing medical education activities are required to disclose to the audience, any relevant commercial interest (which is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience.

FACULTY DISCLOSURES: Hazel Jones-Parker, DNP, FNP-BC discloses that she is on the Speakers Bureaus of Gilead Sciences, Inc., Janssen, and Napo. CME PLANNING COMMITTEE DISCLOSURES: Debra D’Alessandro, MPH and Jennifer Kolker, MPH have no commercial relationships to disclose. Jay Kostman, MD discloses that he receives a research grant from and serves as a consultant to Gilead Sciences, Inc. Helena Kwakwa, MD, MPH discloses that she receives a research grant from ViiV Healthcare. Jay Kostman, MD and Helena Kwakwa, MD, MPH. To the best of their ability, Drs. Kwakwa and Kostman will ensure that any speakers or content they suggest is independent of commercial bias.

FUNDING ACKNOWLEDGEMENT: Partially funded by grants from the Health Resources and Services Administration (HRSA), Bureau of Health Professions, Division of Medicine Grant No. U10HA2995.